BiomX (PHGE) Change in Accured Expenses (2018 - 2023)
BiomX (PHGE) posted Change in Accured Expenses of -$42000.0 for Q3 2023, down 2000.0% sequentially from -$2000.0 in Q2 2023, and down 1300.0% YoY from $3500.0 in Q3 2022.
BiomX (PHGE) Change in Accured Expenses (2018 - 2023) Analysis & Trends
BiomX has reported Change in Accured Expenses for 6 years, with the latest figure at -$42000.0 in Q3 2023.
- Quarterly Change in Accured Expenses fell 1300.0% year-over-year to -$42000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$58000.0 (down 104.93% YoY) and the FY2022 annual result came in at -$27000.0, up 94.44% from the prior year.
- Change in Accured Expenses eased to -$42000.0 in Q3 2023 per PHGE's latest filing, from -$2000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $1.0 million in Q4 2020 and troughed at -$1.8 million in Q1 2020.
- A 5-year average of $16486.9 and a median of $1000.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2019 and 2023: Change in Accured Expenses soared 31800.0% in 2019, then sank 1300.0% in 2023.
- Over 5 years, Change in Accured Expenses stood at $503817.0 in 2019, then jumped by 102.26% to $1.0 million in 2020, then sank by 120.12% to -$205000.0 in 2021, then jumped by 91.22% to -$18000.0 in 2022, then sank by 133.33% to -$42000.0 in 2023.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$42000.0, -$2000.0, and $4000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -42,000.00 |
| Sep 30, 2023 | -42,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -2,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | -18,000.00 |
| Dec 31, 2022 | -18,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Dec 31, 2021 | -205,000.00 |
| Dec 31, 2021 | -205,000.00 |
| Mar 31, 2021 | 365,000.00 |
| Mar 31, 2021 | 365,000.00 |
| Dec 31, 2020 | 1.02 Mn |
| Dec 31, 2020 | 1.02 Mn |
| Sep 30, 2020 | 19,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | -58,000.00 |
| Jun 30, 2020 | -58,000.00 |